Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Slidgigtinstituttet (The Osteoarthritis Institute) was a Danish clinical research institute and specialized clinic based in Ishøj, Denmark, that focused on the study and treatment of osteoarthritis. Founded and led by rheumatologist Keld Østergaard, the institute was primarily active in the early to mid-2000s, conducting clinical research on the efficacy of various therapeutic interventions for joint diseases. The institute gained recognition for its clinical trials on dietary supplements and over-the-counter treatments, most notably glucosamine sulphate, ginger, and avocado-soya unsaponifiables. These studies often evaluated the impact of these substances on chronic joint pain and metabolic markers like blood cholesterol levels. While the institute served as a key site for post-marketing Phase 4 studies in collaboration with partners like Pharma Nord, its research activity has significantly decreased in recent years.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Slidgigtinstituttet.